4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity >99.0% (HPLC)
Ruifu Chemical Supply Lenvatinib Mesylate Inopindirana Nekuchena Kwakanyanya
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Chemical Name | 4-Amino-3-Chlorophenol |
Mashoko anoreva zvakafanana | 3-Chloro-4-Aminophenol;Lenvaint-G |
Nhamba yeCAS | 17609-80-2 |
Nhamba yeCAT | RF-PI1968 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C6H6ClNO |
Molecular Weight | 143.57 |
Density | 1.406±0.060 g/cm3 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Brown Solid Powder |
1 H NMR Spectrum | Zvinoenderana Nechimiro |
Kuzivikanwa-HPLC | Nguva yekuchengetedza yakafanana neyakajairwa |
Kuchena / Analysis Method | >99.0% (HPLC) |
Melting Point | 138.0~141.0℃ |
Kurasika paKuomesa | <1.00% |
Residue paIgnition | <0.30% |
Zvose Zvisina Kuchena | <1.00% |
Test Standard | Enterprise Standard |
Usage | Pakati peLenvatinib Mesylate (CAS: 857890-39-2) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
4-Amino-3-Chlorophenol (CAS: 17609-80-2) inokosha yemishonga yepakati, iyo inoshandiswa zvakanyanya mukugadzira uye kuumbwa kwe anti-tumor, zvirwere zvemwoyo, neurological zvirwere zvinodhaka.4-Amino-3-Chlorophenol inokosha yepakati mukugadzirira kweLenvatinib Mesylate (CAS: 857890-39-2).Yakagadzirwa neEisai Inc., lenvatinib mesylate inonzi vascular endothelial growth factor receptor (VEGF) inhibitor ine chiitiko chinopesana neVEGF subtypes 1, 2, uye 3 uye yakatenderwa neFDA muna 2015 kurapwa kweakasiyaniswa gomarara rethyroid rinowanikwa munharaunda. inodzokororwa, metastatic, kana kufambira mberi uye haina kupindura kune radioactive iodine kurapwa.Muna Chivabvu 2016, FDA yakabvumidza mushonga uyu semusanganiswa wekurapa neeverolimus pakurapa renal cell carcinoma.Nemhaka yokuti VEGF (uye fibroblast growth factor receptors, inozivikanwa seFGFRs) inofungidzirwa kuti inobata basa mumigwagwa yemwoyo yemwoyo, VEGF2R uye FGFR inhibition inofungidzirwa kuti ndiyo nzira dziri shure kwechikamu chekutanga chelenvatinib mesylate, iyo hypertension.